The Unilever share price: after an 11% leap, am I too late to buy?

The Unilever share price first slumped and then jumped after it abandoned a £50bn deal. Have I missed my chance to buy Unilever shares on the cheap?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In the US, investors are worried about a substantial stock market crash. Meanwhile, UK stocks have held up pretty well so far in 2022. In fact, the FTSE 100 index has gained more than 105 points (+1.4%) since 31 December. Perhaps because the Footsie is unloved and undervalued, as I’ve repeatedly argued throughout 2020-21? Indeed, I still view many FTSE 100 stocks as firmly in bargain-bin territory. That’s why I’ve kept a close eye on the Unilever (LSE: ULVR) share price, which has been on a roller-coaster ride since mid-January.

The Unilever share price drops and then pops

The Unilever share price has recorded only modest gains over the past five years. Here’s how this popular stock has performed from 2016 to 2021 (excluding dividends):

  Closing price

Yearly change

2021 3,945.5p -10.2%
2020 4,392.0p 1.0%
2019 4,350.5p 5.9%
2018 4,108.5p -0.4%
2017 4,125.5p 25.3%
2016 3,292.5p N/A

The Unilever share price had a great 2017, soaring by more than a quarter (+25.3%). Alas, it failed to hit the heights over the next four years, falling by 0.4% in 2018 and losing more than a tenth (-10.2%) last year. Hardly the returns one might hope for from a widely admired, quality business, right?

As I write, the Unilever share price stands at 3,833.72p, down 102.28p (-2.6%) on Tuesday’s close. At this level, the consumer-goods giant is valued at a mighty £97.9bn, making it the third-largest company in the FTSE 100 index. This also leaves it down 111.78p (-2.8%) so far this calendar year.

However, following a failed £50bn bid for GlaxoSmithKline‘s Consumer Health arm (GSKCH), Unilever shares went into a tailspin. After closing at 3,936.5p on 14 January, the Unilever share price plunged as low as 3,450p on Friday morning (19 January), before rebounding strongly this week. Indeed, since Friday’s low, ULVR has leapt by a ninth (+11.1%) in under four days.

Did I miss buying Unilever on the cheap?

Last week, both Unilever’s share price and its management took a battering from major shareholders and financial pundits. Many criticised Unilever chief executive Alan Jope and chief financial officer Graeme Pitkethly for what they saw as an imprudent and over-priced bid for GSKCH. There were even calls for change at the very top of Unilever’s management team.

As the Unilever share price slid, I decided that it was high time to ‘press the button’ to add Unilever stock to my family portfolio. Unfortunately, I then fell ill (but not with Covid-19), missing my chance to buy at what I considered to be a bargain price below £35. Rats!

So my big question now is: have I missed out buying while the Unilever share price still offers value? At their current level, Unilever shares trade on a price-to-earnings ratio of 22.2 and an earnings yield of 4.5%. The dividend yield — almost 4.3% a year at Friday’s low point — now stands at nearly 3.9%. That’s broadly in line with the FTSE 100’s dividend yield of around 4% a year.

Although these fundamentals are not as attractive as they were on Friday, they’re good enough for me. Hence, my wife — the portfolio administrator — will shortly add ULVR to our holdings. We’ll see how this beaten-down stock will get on over the next five to 10 years. However, Unilever and its share price faces several high hurdles. Famed activist investor Nelson Peltz has built up an undisclosed stake in the group. Unilever announced 1,500 job cuts this week. And more restructuring news follows in February. Hence, let’s see what happens next…

Cliffdarcy owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services, such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool, we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Happy parents playing with little kids riding in box
Investing Articles

Up 12% in a month, Hollywood Bowl is a UK dividend stock on a roll

This 5%-yielding dividend stock was one of the top performers in the FTSE 250 index today. What sent it flying…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

Young investors are taking the stock market on a rollercoaster ride. Here’s how retirees can buckle up

Mark Hartley reveals the volatile impact that younger investors are having on the stock market and how UK retirees can…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

£7,500 invested in Aviva shares 5 years ago is now worth…

A lump sum pumped into Aviva shares half a decade ago has grown a lot. Andrew Mackie looks at the…

Read more »

Young female hand showing five fingers.
Investing Articles

Could £20,000 invested in these 5 dividend shares produce £14,760 of passive income over the next 10 years?

James Beard considers the potential of dividend shares to deliver amazing levels of passive income. Here are five that have…

Read more »

Workers at Whiting refinery, US
Investing Articles

At 570p, is it too late to consider buying BP shares?

Since the end of February, when the conflict in the Middle East started, BP shares have soared nearly 20%. But…

Read more »

Aviva logo on glass meeting room door
Investing Articles

5 years ago, £5,000 bought 1,231 Aviva shares. But how many would it buy now?

Buying Aviva shares in April 2021 would have been a good decision. And the insurance, wealth, and retirement group’s dividends…

Read more »

Nottingham Giltbrook Exterior
Investing Articles

5 years ago, £5,000 bought 3,185 Marks & Spencer shares. But how many would it buy now?

According to a recent survey, Marks & Spencer is the UK’s best brand. Does this mean it’s time to consider…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Is the 8.7% yield on this FTSE 250 stock too good to be true?

FTSE 250 stocks are often overlooked by income investors. Here’s one that’s currently (15 April) yielding over twice that of…

Read more »